
TAD
NCT04671511
Targeted Axillary Dissection (TAD) in Early-stage Node Positive Breast Cancer (TADEN)
Status:
Recruiting

Phase

Neoajduvant
Line of Therapy

Early Cancer
Disease Stage

Biomarker(s)
Investigational
Product
n/a
Sentinel node biopsy and clipping and removing node
Treatment Arms
o Targeted Axillary Dissection